Two Sigma Investments’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.97M Buy
4,633,451
+4,236,457
+1,067% +$7.29M 0.01% 930
2025
Q1
$1.32M Buy
+396,994
New +$1.32M ﹤0.01% 1956
2024
Q4
Sell
-92,368
Closed -$867K 3274
2024
Q3
$867K Sell
92,368
-682,415
-88% -$6.41M ﹤0.01% 2149
2024
Q2
$6.21M Buy
+774,783
New +$6.21M 0.01% 860
2023
Q4
Sell
-227,000
Closed -$1.03M 3161
2023
Q3
$1.03M Sell
227,000
-1,304,053
-85% -$5.93M ﹤0.01% 1845
2023
Q2
$10.8M Sell
1,531,053
-1,026,134
-40% -$7.22M 0.03% 569
2023
Q1
$15.6M Buy
2,557,187
+1,663,254
+186% +$10.2M 0.04% 416
2022
Q4
$5.71M Sell
893,933
-517,225
-37% -$3.31M 0.02% 768
2022
Q3
$13.5M Buy
1,411,158
+877,558
+164% +$8.41M 0.05% 394
2022
Q2
$5.89M Buy
533,600
+408,700
+327% +$4.51M 0.02% 674
2022
Q1
$2.08M Sell
124,900
-256,981
-67% -$4.28M 0.01% 1304
2021
Q4
$7.29M Buy
381,881
+122,951
+47% +$2.35M 0.02% 761
2021
Q3
$6.39M Buy
+258,930
New +$6.39M 0.01% 781
2021
Q2
Sell
-170,300
Closed -$5.39M 2632
2021
Q1
$5.39M Sell
170,300
-136,862
-45% -$4.33M 0.01% 792
2020
Q4
$14.3M Buy
307,162
+296,426
+2,761% +$13.8M 0.04% 418
2020
Q3
$353K Sell
10,736
-77,873
-88% -$2.56M ﹤0.01% 1531
2020
Q2
$2.43M Buy
+88,609
New +$2.43M 0.01% 805
2020
Q1
Sell
-189,327
Closed -$5.24M 2158
2019
Q4
$5.24M Sell
189,327
-312,443
-62% -$8.65M 0.02% 720
2019
Q3
$9.13M Buy
+501,770
New +$9.13M 0.03% 464
2019
Q2
Sell
-149,841
Closed -$1.43M 2228
2019
Q1
$1.43M Sell
149,841
-201,691
-57% -$1.92M ﹤0.01% 1298
2018
Q4
$3.11M Buy
+351,532
New +$3.11M 0.01% 891
2018
Q3
Sell
-263,475
Closed -$3.37M 2174
2018
Q2
$3.37M Buy
263,475
+249,075
+1,730% +$3.19M 0.01% 874
2018
Q1
$243K Sell
14,400
-13,894
-49% -$234K ﹤0.01% 1790
2017
Q4
$226K Buy
+28,294
New +$226K ﹤0.01% 1999